Substance Use Treatment

Meet Our Experts: Substance Use Counselors

Tanikka Cappell, BSW
Jose Torres, MS | bilingual
Maggie Zecher, MA | Certified Cognitive Behavioral Therapist | bilingual

APM was the first agency in Philadelphia to provide treatment for substance use disorder designed for the Latino community. We offer structured, evidence-based intensive, and regular outpatient services to adolescents and adults with substance use and related disorders.

APM’s staff culturally sensitive engage in creating a personalized treatment plan for each participant that is focused on recovery management. Our services include extensive health and social service programs proven to reduce factors that trigger high-risk situations for people with substance use disorder.

Participants must:

• Complete intake process, including urine screening and laboratories.
• Be examined by our therapist and physicians
• Have medical insurance, private pay and/or proof of identity

How does it work?

• Individual therapy sessions with a trained Substance use Counselor
• Group sessions
• Relapse prevention
• Behavioral Health Education
• Monthly Medication Management appointments with a physician

Key Offerings

Medication for Assisted Treatment (MAT)

Buprenorphine (Cizdol, Suboxone, Subutex, Zubsolv, Bunavail, Sublocade), in combination with counseling and behavioral therapies, provides a personalized approach to the treatment of opioid use disorder. If taken as prescribed, buprenorphine is safe and effective (SAMHSA, 2019).

Naltrexone (ReVia, Depade, Vivitrol), is prescribed for both alcohol and opioid use disorder. The medication blocks the euphoric and sedative effects of these substances by binding and blocking opioid receptors.

Works together with counseling and therapy, allowing people with alcohol use and related disorders to reduce their drinking behaviors and avoid relapses. Naltrexone is not addictive, nor does it react adversely with alcohol(SAMHSA, 2019).

Other medications that are FDA approved as MAT for alcohol use disorder are available for participants. these include Acamprosate (Campral) and disulfiram (Antabuse and Antabus): Both medications are used together with behavior modification and counseling to assist people with alcohol use disorders who has recently quit drinking alcohol to stay in recovery.

MAT participants should:

• Have been objectively diagnosed with an opioid use disorder
• Follow safety precautions for the treatment, including follow-ups with primary care physician and treatment of chronic medical illnesses.
• Have reviewed treatment options before agreeing to buprenorphine or naltrexone treatment
• Multilingual Treatment Services
• Outpatient level of care
• Intensive Outpatient Program
• Treatment Court Outpatient

Contact us at our clinic locations:

4301 Rising Sun Avenue, Philadelphia, PA 19140, ph. 267.296.7220 option #1; (fax 215.324.1153)
3169 N 5th St, Philadelphia, PA 19133, ph. 267.296.7220 option #2; (fax 267.329.9728)
112 E Allegheny Ave, Philadelphia, PA 19134, ph. 267.296.7220 option #7; (fax 215.291.8069)
2927 N 5th St, Philadelphia, PA 19133, ph. 267.296.7220 option #6; (fax 215.426.9683)

Monday – Friday 7:00 AM to 6:00 PM.
Evening hours are available by appointment

Drug & Alcohol 2016 Annual Report